Literature DB >> 22990930

[Clinical application of minimally invasive esophagectomy for esophageal carcinoma].

Shuo-yan Liu1, Feng Wang, Qing-feng Zheng, Xiao-feng Chen.   

Abstract

OBJECTIVE: To investigate the feasibility and safety of minimally invasive esophagectomy (MIE) for esophageal carcinoma.
METHODS: Clinical data of 298 esophageal carcinoma cases who were treated by MIE in the Fujian Provincial Cancer Hospital from June 2008 to April 2012 were retrospectively reviewed.
RESULTS: All the patients underwent MIE successfully except one conversion to open surgery. The mean operative time was (242.3±58.7) min. The postoperative length of hospital stay was (17.4±9.8) d. The number of harvested lymph nodes of total, the mediastinum, the abdomen and the cervix was 27.5±12.2, 10.7±5.7, 13.3±7.8, and 7.7±8.1, respectively. Postoperative complication rate was 29.9%, including pneumonia (n=41), recurrent laryngeal nerve injury (n=25), anastomotic leak (n=9), wound infection (n=7), and others (n=7). After follow up of 2 to 47 months, 3 patients were found to develop anastomotic stricture. There were no recurrence, metastasis, or death.
CONCLUSION: Minimally invasive esophagectomy is a safe, feasible, effective and minimally invasive surgical technique.

Entities:  

Mesh:

Year:  2012        PMID: 22990930

Source DB:  PubMed          Journal:  Zhonghua Wei Chang Wai Ke Za Zhi        ISSN: 1671-0274


  2 in total

1.  Minimally invasive esophagectomy for esophageal cancer in the People's Republic of China: an overview.

Authors:  Chengchu Zhu; Ketao Jin
Journal:  Onco Targets Ther       Date:  2013-03-03       Impact factor: 4.147

2.  Application of pleural flaps in laparoscopic-thoracoscopic esophagectomy for esophageal cancer.

Authors:  Xiaofeng Chen; Shuoyan Liu; Peng Chen; Hao He; Feng Wang
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 3.005

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.